教授 太和田　暁之

太和田　暁之　研究業績（外部サイト）

博士（医学）

1. 人体の構造と機能I
2. 人体の構造と機能II
3. 人体の構造と機能III
4. 病態学I
5. 病態学III
6. 臨床検査論
7. 内科学概論
8. 高齢者医療論
9. 画像診断学
10. 体験ゼミナール

がんの遺伝子診断と分子標的療法

臨床腫瘍学

消化器内科学

1: Tawada A, Kanda T, Imazeki F, Yokosuka O. Prevention of hepatitis B virus- associated liver diseases by antiviral therapy. Hepatol Int. 2016 Jul;10(4):574-93.

2: Tawada A, Chiba T, Saito T, Ogasawara S, Suzuki E, Ooka Y, Arai M, Kanda T, Shinozaki M, Goto N, Nagashima K, Yokosuka O. Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues. Oncology. 2016;90(4):199-208.

3: Tawada A, Kanda T, Yokosuka O. Current and future directions for treating hepatitis B virus infection. World J Hepatol. 2015 Jun 18;7(11):1541-52.

4: Tawada A, Chiba T, Ooka Y, Kanogawa N, Saito T, Motoyama T, Ogasawara S, Suzuki E, Kanai F, Yoshikawa M, Yokosuka O. Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma. Anticancer Res. 2015 Jan;35(1):549-54.

5: Tawada A, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Saito T, Ogasawara S, Suzuki E, Maruyama H, Kanai F, Yoshikawa M, Yokosuka O. Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma. Anticancer Res. 2014 Aug;34(8):4231-7. PMID:

25075052.

6: Tawada A, Kanda T, Oide T, Tsuyuguchi T, Imazeki F, Nakatani Y, Yokosuka O.

18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis. Int Med Case Rep J. 2014 Jun 20;7:103-9.

7: Tawada A, Chiba T, Ooka Y, Yokota H, Kanogawa N, Motoyama T, Saito T, Ogasawara S, Suzuki E, Hanari N, Matsubara H, Saeki N, Kambe M, Kishimoto T, Nakatani Y, Yokosuka O. Intracranial metastasis in a patient with hepatocellular carcinoma and gastric cancer. Case Rep Oncol. 2014 Mar 14;7(1):199-203.

8: Tawada A, Maruyama H, Kamezaki H, Shimada T, Ishibashi H, Takahashi M, Kanda T, Fujiwara K, Imazeki F, Yokosuka O. Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models. Hepatol Int. 2013 Jun;7(2):749-57.